Background. There is a need for solid evidence of the relative advantages of universal vs. selective screening for gestational diabetes mellitus. Our study of a broad obstetric population determines the positive predictive value of the 50-g oral glucose challenge test for screening in the presence and absence of classical gestational diabetes risk factors. Methods. A retrospective cohort study was carried out with a total of 2,574 pregnant women. Clinical information was obtained from hospital records and each patient's medical history, and gestational diabetes risk factors were quantified for each pregnant woman. The positive predictive value of a screen was determined with respect to the number of risk factors. Results. Age 30 or over, family history of diabetes, obesity (BMI Ø27) and previous fetal macrosomia were established as the most frequent risk factors. Just over half (54.2%) of our population presented one or more risk factors. Screening covered 75% of the population, and was positive in 15% of the cases. Diagnosis was confirmed in 64 cases, 57 of them at risk, and seven with no risk factors. We obtained an overall positive predictive value of 21.8% . This figure increases with the number of risk factors, from 12% for the women with no risk factors, to 40% for those presenting three or more risk factors. Conclusions. A selective screening program that takes into account the clinical background and characteristics of each pregnant woman allows a high yield of true positives while reducing the possible undesirable effects associated with false positives.
GDM screening, involving historic and clinical risk factors alone, oral glucose challenge tests, random glucose sampling, glycosylated hemoglobin, or the determination of fructosamine for example (18, 19) . The most widely used is the 50-g oral glucose challenge test (GCT), and determination of glycemia one hour later. There is no global consensus, however, with regards to the cutoff point for classifying results as positive or negative. The threshold value used most often is 7.8 mmol/l, as O'Sullivan and his colleagues established (20) ; yet there are medical professionals who propose lowering this value to 7.2 or 7.5 mmol/l in order to increase the sensitivity of the test (2) .
There is insufficient evidence to recommend for or against routine screening for GDM (21) , and this subject continues to create debate at present (22) (23) (24) (25) . Whereas the WHO recommends the universal screening of pregnant women (26) , the American College of Obstetricians and Gynecologists (ACOG) (27) and the American Academy of Pediatrics (28) recommend that only those women presenting risk factors should be screened. In 1997, The American Diabetes Association (ADA) modified its universal stand, now recommending that only pregnant women over 25 years of age and/or with at least one risk factor be screened (29) . This proposal was ratified one year later in the Fourth International Workshop-Conference on Gestational Diabetes Mellitus (30) .
The application of either systematic or selective GDM screening has important implications for the yield of the screen. The positive predictive value (PPV) of the test (that is, the probability of disease in a patient with a positive test result) and the negative predictive value (NPV) (indicating the accuracy of the negative results) depend directly on the prevalence of the disease in a population. A greater prevalence would result in a higher PPV and a lower NPV; and vice-versa (31, 32) . Because GDM may be seven or eight times more prevalent in gestating women with risk factors (33) , a positive result should be interpreted with some consideration of the presence or absence of risk factors in the woman. This premise led us to analyze the predictive value of a positive 50-g oral glucose challenge test (GCT) with regards to the number of GDM risk factors per pregnant woman.
Material and methods
A retrospective cohort study was designed with the approval of a medical ethics committee, the eligible population consisting of all the pregnant women who gave birth at the Hospital Clínico San Cecilio (HCSC) between Jan. 1 and Dec. 31 of the year 1995. The HCSC is a tertiary hospital that oper-C Acta Obstet Gynecol Scand 79 (2000) ates under the Andalusian Health Service (Servicio Andaluz de Salud). With 750 beds, it serves as the center of referral for the approximately 425,000 inhabitants of the southern half of the Province of Granada (Andalusia, Spain). As a maternity hospital, it covers approximately 290,000 inhabitants. The criteria for inclusion in the study were: giving birth in the HCSC in 1995, regular residence and medical attention in the area of referral of the HCSC, simple pregnancy, a first doctor visit before week 28 of gestation, and gestational age at delivery at least 28 weeks. The criteria for exclusion were: diabetes type 1, type 2, or carbohydrate intolerance diagnosed before pregnancy, pregnancy not under medical control, and pregnancies and deliveries entailing a high obstetric risk which led them to be attended at this hospital.
Of the 2,780 deliveries assisted at the HCSC in 1995, medical records were located for only 2,730; and of these, 2,574 fulfilled all the inclusion criteria and therefore made up our study population. The reasons for exclusion included: loss of medical record and impossibility of otherwise obtaining vital information (50 cases), multiple birth (39 women), antecedent of diabetes (9) , lack of medical control of pregnancy (21) , first visit later than week 28 of gestation (24) , birth occurring before week 28 (4), and having residence or usual medical attention outside the area of referral of the HCSC (9).
Spain's National Health Service has a free prenatal care program for all pregnant women. Since 1984, Andalusian public health policy urges screening all pregnant women between the 24th and 28th week of gestation, with a 50-g GCT followed one hour later by plasma glucose determination (34). Glycemia over 7.8 mmol/l is considered positive, requiring a confirmatory 100-g oral glucose tolerance test (OGTT). In the presence of GDM risk factors, it is recommended that testing be moved up to the first doctor visit, and repeated after the 24th week of gestation if the initial result is negative. Testing is performed and results are interpreted in accordance with the guidelines set forth by the National Diabetes Data Group (29) . Pathology is indicated by glycemia that surpasses two or more of the following values: 5.8 mmol/l in a fasting state, 10.6 mmol/l after one hour, 9.2 mmol/l after two hours and 8.1 mmol/l after three hours. Glycemia is determined from the venous plasma glucose, using the hexokinase method (Hitachi 747, Hoffmann LaRoche, Basel, Switzerland).
The information sources used were the hospital register of birth, the medical record of the mother, and the maternal health booklet when possible. The birth register (libro de partos), an official volume kept at all hospitals and filled out as a require-ment under Spanish legislation (35) was the primary source of information. It contains the name, age and address of each parturient, the number of her medical record, date of delivery, number of previous children and pregnancies, type of pregnancy, antecedents, obstetric formula, and relevant information about delivery and the health of the newborn, such as Apgar score. The maternal health booklet (documento de salud maternal), on the other hand, contains the data recorded at each monthly checkup during pregnancy (number of visit, week of gestation, maternal weight, blood pressure and general observations, antecedents, results of analytical or ultrasound, and specification of any medication or treatment).
The medical record of the mother was the principal information source. It provided information about personal and family antecedents, obstetric antecedents, evolution of the pregnancy in question, delivery, and final result of gestation (overall state of the neonate's health). When information was missing, an attempt was made to complete the data by mail or telephone calls to the mother.
The following GDM risk factors were used in our study: maternal age 30 or over, body mass index (BMI)±27, history of diabetes mellitus in a first-degree relative, history of GDM or macrosomia, chronic hypertension, polyhydramnios, hypertension induced by the pregnancy, suspected large fetus for gestational age, and an obstetric history including two or more miscarriages, perinatal mortality or congenital malformations in previous pregnancies. Macrosomia was defined as a birth weight over 4,000 g. Antepartum surveillance included serial ultrasound examinations to assess biparietal diameter, femur length and fetal growth. A suspected large fetus for gestational age was defined as an estimated fetal weight over 2 s.d. according to intrauterine growth tables adapted for the Spanish population. Information concerning the GCT included whether or not results were obtained, during which week of gestation it was performed, and the results of glycemia in a fasting state and one hour after the load. Likewise, we recorded whether a confirmatory diagnosis (OGTT) was obtained, and if so, noted the week of gestation and the fasting, 1-h, 2-h and 3-h results of the glucose determinations. All fundamental information was obtained for 2,380 of the pregnant women. The data missing in the remaining 194 parturients essentially involved the evolution of the pregnancy in question and the performance of the GDM screen or diagnosis. Nonetheless, it was ascertained that in 143 of these 194 women (74%) gestation had run a normal course, and in 14 (7%) there had been some pathology other than diabetes; while in the other 37 (19%) there was no reference to the pregnancy or its evolution.
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In the analysis of our data, PPV was calculated as the ratio of the true positives (positive screening confirmed by positive diagnosis of GDM) divided by the total number of pregnant women who had screened as positive (true positives and false positives) (31, 32) . The PPV was obtained for the whole study population and stratified with respect to the type and the number of risk factors determined. The Pearson c 2 test was used for the comparison of proportions, and the Student's t test and the Mann-Whitney test when necessary for the comparison of means; pϽ0.05 was considered significant. The statistical analysis was carried out with the SPSS 8.0 program (36) . PPV confidence intervals were calculated using the Epi Tables option of Epi Info 6.04a (37) . Table I gives the obstetric characteristics of our study population. The mean age of the pregnant women surveyed was 29 (s.d. 4.98). It was the first pregnancy for 946 of the women, whereas it was Screening was recorded in 1,961 of the women (76.2%), was not done in 425 cases (16.5%), and was not known in 188 women (7.3%). The screening and diagnostic program for the disease had been carried out according to the recommendations of the National Diabetes Data Group (29) in 75% of the pregnant women. The GCT had been performed, on average, in the 25th week of gestation (s.d. 3.38), with a range of week 8 to week 34. It was positive for 294 women (15%). Mean glycemia was 9.1 mmol/l (s.d. 1.2) among these women with initial positives. Mean glycemia was checked for significant differences with regard to the presence of risk factors; in women at risk, the mean was 9.2 mmol/l (s.d. 1.2), whereas in women without risk factors it was 8.6 mmol/l (s.d. 0.9) (pϽ0.001). Glycemia was also seen to increase with the number of risk factors: the mean was 8.9 mmol/l for women with just one risk factor, and 9.4 mmol/l for those with three or more risk factors (pϽ0.001). Table III indicates the results of the screening and diagnosis according to the number of risk factors per woman, as well as the prevalence of GDM and the PPV. Screening covered 70% of the women presenting no risk factors, and increased its coverage with the number of risk factors present per woman (pϽ0.001), achieving nearly 100% coverage in women with three or more risk factors. The week of screening was also related with the number of factors: the greater the risk, the earlier the testing (pϽ0.001). The mean week of screening was the 26th (s.d. 2.9) in women without risk factors, whereas in women with four risk factors it was the 22nd week (s.d. 5.2).
Results
Of the 294 women shown to be GDM positive in the oral GCT, 235 presented risk factors, whereas 59 presented none. The probability of a positive screen increased with the number of risk factors: 7.4% of the women with no risk factors, 20.2% of the women with one or more, and up to a maximum of 38% in those women with three or more risk factors (pϽ0.001) ( Table III) .
The 100-g OGTT was used to confirm diagnosis in 259 of the 294 women giving initial positives (88%). The confirmatory test was not performed in 35 women who presented no risk factors other than age (22 were 30 or over). The results of GCT showed mean glycemia to be lower in the women with no confirmatory diagnosis than in those for whom OGTT was performed: respectively, 8.1 mmol/l (s.d. 0.3 and range 7.8 to 8.8 mmol/l) and 8.7 mmol/l (s.d. 0.9). GDM diagnosis was confirmed in 64 cases, 57 of them with risk factors, and seven without (Table III) .
The PPV of the GCT was determined to be 21.8% (17.3-27.0) if the 35 unconfirmed cases are included, or 24.7% (19.7-30.5) if only the 259 cases with confirmatory diagnosis are considered. This means that in our obstetric population overall, for each 10 correct diagnoses, there were 36 false positives. The PPV was seen to increase significantly with a greater number of risk factors, from 12% in the absence of risk to 40% when three or more risk factors were present (pϽ0.001) (Table III) . Table  IV indicates the result of GDM screening, diagnosis and the PPV according to individual risk factors. The greater PPVs were for antecedents of hypertension or GDM (respectively, 60% and 57%), followed by antecedents of macrosomia (37.5%), obesity (BMIϾ27; 32.5%), and a history of diabetes mellitus in a first-degree relative (25.9%). When obesity was defined as a BMIϾ30, the PPV C Acta Obstet Gynecol Scand 79 (2000) went up to 39%, being the third risk factor in importance.
Discussion
A number of options exist with regard to screening for GDM. Screening may be considered unnecessary (38) , may be directed exclusively at women running a special risk (27) (28) (29) (30) , or may be done on a routine, universal basis in obstetric populations (26) . Each one of these alternatives has its proponents and critics. From a pragmatic standpoint, however, health professionals focus the debate on systematic vs. selective screening. The U.S. Preventive Task Force (21) affirms that, given the lack of conclusive data in favor or against routine screening, it can merely be recommended for women with GDM risk factors.
In Andalusia (Spain), the Mother-Infant Health Program developed in the 80's by the Regional Government (Programa de Salud Materno Infantil de la Junta de Andalucía) recommends that all pregnant women be tested for GDM (34). Interestingly enough, our study revealed that despite the official recommendation, the performance and timing of screening were actually more closely re-lated with the presence or absence of risk factors. Our documentation confirmed that 76% of the population had been screened for certain. This figure would be 83% if the test had in fact been run on the 188 for whom screening was 'unknown'; in other words, roughly 20% of the population slipped through the 'universal screen'. Other authors (39) (40) (41) point out similar discrepancies between official guidelines, surveyed preferences and the reality of clinical practice. Evidently, the lack of objective criteria for adapting a single, coherent and uniform stance -either selective or universal screening -tends to result in a mixed standard in clinical practice.
The prevalence of GDM observed in our population was 2.5% (1.9-3.2), which is consistent with the figures for expected prevalence in industrialized countries (26, 29) of roughly 2% to 5% of all pregnant women. Although all the pregnant women of our study gave birth in a tertiary hospital, they can be considered representative of a general obstetric population. The HCSC is a public hospital, and as a maternity hospital it covers approximately 290,000 inhabitants. Both pregnancies supervised mainly by the obstetrician in the hospital unit and those supervised by family practitioners and obstetricians outside the hospital are assisted in the HCSC. Only a very minor bias could be produced by the populational loss of the gestating women who delivered at a private hospital, approximately 8% in our area. Our study excluded all pregnancies and deliveries involving a high obstetric risk which, under normal circumstances, would have been attended to at other hospitals. The fact that our values are similar to the findings of other population-based studies (42) (43) (44) would support the validity of our sample. Our figure for prevalence among women without risk factors was 0.6% (0.3-1.2), and with risk factors 4.0% (3.0-5.1). This prevalence of 0.6% among a population with no risk factors gives a PPV of 12%. That is, for each true positive there are 7.7 false positives.
The possibility of false positives and iatrogenic problems gives rise to a consideration of the ethical implications of performing the GCT on healthy pregnant women (31) . The GCT, like many other diagnostic tests, may have repercussions of an iatrogenic nature. Though the GCT is known to be a safe method, some patients complain that drinking the glucose solution makes them dizzy or nauseated, and vomiting may make it impossible to complete the trial (19) . The false positives may also result in cases of labeling effect, such as has been documented by Kerbel et al. (45) . In this study, false positives were found to present poorer selfperceived health than women with a negative GCT. Other studies, however, describe favorable or neu-C Acta Obstet Gynecol Scand 79 (2000) tral attitudes on the part of women who are screened, diagnosed or treated for GDM (46, 47) .
In the case of our study, a selective screening program (women 30 years old or over and/or presenting some GDM risk factors) would have meant diagnosing 11% fewer cases of GDM (seven out of 64). At the same time, 800 women would have been spared the screening process. The potential loss of some cases of GDM among women free of risk would appear relatively irrelevant if a greater risk of short-term complications is associated with the presence of risk factors (43, (48) (49) (50) , which in some cases may affect the health of a gestating woman more than GDM itself. Indeed, recent studies show a reduced risk of complications associated with the disease that may be related with better metabolic and obstetric monitoring of the patient, and/or with the inclusion of less serious cases of the disease as a result of universal screening (51) . The choice between universal or selective screening implies a consideration of the complications and costs of the false positives deriving from universal screening, as well as those of false negatives associated with selective screening. In this context, out of the seven cases of GDM that we diagnosed in women without risk factors, only one related complication was seen: a case of neonatal hypoglycemia. Therefore, the risk of complications would appear to be reduced in women who do not present risk factors, although our data do not allow us to affirm whether this might be the consequence of a better metabolic control, a lack of statistical power or simply the absence of risk factors in these women.
According to our findings, the higher the number of risk factors, the higher the PPV of the GCT. This statement suggests the advantages of selective screening. As our study calculated PPV by taking into account the number but not the type of risk factor, it may be argued that a 32-year-old pregnant woman with antecedents of macrosomia does not necessarily run the same risk as a 29-year-old who is obese and has a history of GDM. When the different risk factors are considered separately, the greater PPVs are seen for antecedents of GDM or hypertension (57% and 60%, respectively), followed by previous macrosomia (37.5%) and obesity (BMIØ27), with a 32.5% predictive value. These predictive values are approximately three times higher than those obtained in women without any risk factors. On the other hand, when we considered age alone (regardless of the other risk factors) the PPV was only slightly higher, increasing from 19% in women age 25 and under, to 23% in those over 30. Some caution should be used in interpreting these values, as a pregnant woman may present simultaneously more than one import-ant GDM risk factor. Nevertheless, our findings come to support the conclusions of Naylor et al. (44) , who defend selective screening based on a combination of the clinical characteristics of the woman. This type of criterion would mean fewer tests performed and fewer false positives, but without affecting the number of confirmed cases of GDM.
In conclusion, our results point to a greater positive predictive value when selective criteria are applied to screening for GDM. This finding comes to support the position adopted by groups such as the ACOG (27) , the ADA (29), or the U.S. Preventive Task Force (21) .
